OUTLOOK THERAPEUTICS, INC.: 10-K filed 2024-12-27

Name: OUTLOOK THERAPEUTICS, INC.: 10-K filed 2024-12-27
Creator: OUTLOOK THERAPEUTICS, INC.

What OUTLOOK THERAPEUTICS, INC. reported in its annual report filed 2024-12-27 (fiscal FY 2024): 35 published measures, 71 facts as tagged in accession 0001558370-24-016491.

This filing

Form: 10-K (annual report)
Filed: 2024-12-27
Fiscal period: fiscal FY 2024
Accession: 0001558370-24-016491 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All OUTLOOK THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2024-09-30	28,823,154	USD
At 2023-09-30	32,300,601	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2024-09-30	101,899,664	USD
At 2023-09-30	46,738,378	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2024-09-30	-73,076,510	USD
At 2023-09-30	-14,437,777	USD
At 2022-09-30	8,736,571	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2024-09-30	14,927,538	USD
At 2023-09-30	23,391,982	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	-75,366,714	USD	366
2022-10-01 to 2023-09-30	-58,982,668	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	-68,793,858	USD	366
2022-10-01 to 2023-09-30	-42,973,398	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	60,329,414	USD	366
2022-10-01 to 2023-09-30	48,968,568	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2024-09-30	-543,284,900	USD
At 2023-09-30	-467,918,186	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	18,548,813	shares	366
2022-10-01 to 2023-09-30	12,508,817	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	18,548,813	shares	366
2022-10-01 to 2023-09-30	12,508,817	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	-4.06	USD/shares	366
2022-10-01 to 2023-09-30	-4.72	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	-4.06	USD/shares	366
2022-10-01 to 2023-09-30	-4.72	USD/shares	365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	2,800	USD	366
2022-10-01 to 2023-09-30	2,800	USD	365

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	5,385,124	USD	366
2022-10-01 to 2023-09-30	5,547,019	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	-71,703,235	USD	366
2022-10-01 to 2023-09-30	-53,126,382	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2024-09-30	27,416,036	USD
At 2023-09-30	30,979,198	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2024-09-30	42,553,729	USD
At 2023-09-30	46,732,159	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2024-09-30	7,968,725	USD
At 2023-09-30	6,574,523	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	41,763,047	USD	366
2022-10-01 to 2023-09-30	26,452,942	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2024-09-30	23,905,635	shares
At 2023-09-30	13,012,833	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2024-09-30	14,927,538	USD
At 2023-09-30	23,391,982	USD
At 2022-09-30	17,396,812	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2024-09-30	274,645	USD
At 2023-09-30	26,172	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2024-09-30	297,829	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2024-09-30	439,283	USD
At 2023-09-30	501,299	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2024-09-30	3,237,468	USD
At 2023-09-30	2,745,740	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2024-09-30	12,488,498	USD
At 2023-09-30	7,587,216	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2024-09-30	77,203	USD
At 2023-09-30	7,357	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	-75,363,914	USD	366
2022-10-01 to 2023-09-30	-58,979,868	USD	365

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	-75,366,714	USD	366
2022-10-01 to 2023-09-30	-58,982,668	USD	365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	29,940,188	USD	366
2022-10-01 to 2023-09-30	26,673,440	USD	365

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	3,156,964	USD	366
2022-10-01 to 2023-09-30	2,531,228	USD	365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	475,000	USD	366
2022-10-01 to 2023-09-30	1,160,008	USD	365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	60,333,681	USD	366
2022-10-01 to 2023-09-30	30,024,213	USD	365

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	14,514	USD	366
2022-10-01 to 2023-09-30	27,675	USD	365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2023-10-01 to 2024-09-30	1,394,202	USD	366
2022-10-01 to 2023-09-30	3,083,038	USD	365

Inspect the source

Entity: OUTLOOK THERAPEUTICS, INC. / CIK 0001649989
Captured: 2026-09-21T17:23:24.422Z
SEC response SHA-256: ce697e8c1ac203fe6827508f0d6a14f8a445ce42f9c031026a98c3f5635933f0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001649989.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))